How do pathogens drive the evolution of paired receptors?

European Journal of Immunology

Volumn 43, Issue 2, 2013, Pages 303-313

  Akkaya, Munir ^a   Barclay, A Neil ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Evolution; Host pathogen interactions; Paired receptors

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CD200 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A; NATURAL KILLER CELL RECEPTOR NKG2A; PAIRED RECEPTOR; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTERIVIRUS; BACTERIAL COLONIZATION; BINDING SITE; CELL ACTIVATION; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; EVOLUTION; EXON; GENE DUPLICATION; HERPES VIRUS; HOST PATHOGEN INTERACTION; HUMAN; LATENT PERIOD; LEUKOCYTE; MYXOMA VIRUS; NATURAL KILLER CELL; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; VIRUS ENTRY; VIRUS RESISTANCE;

ANIMALS; EVOLUTION, MOLECULAR; HOST-PATHOGEN INTERACTIONS; HUMANS; MEMBRANE PROTEINS; RECEPTORS, CELL SURFACE;

EID: 84873712375     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242896     Document Type: Review

References (101)

1. Carlyle, J. R., Mesci, A., Fine, J. H., Chen, P., Belanger, S., Tai, L. H.andMakrigiannis, A. P., Evolution of the Ly49 and Nkrp1 recognition systems. Semin. Immunol. 2008. 20: 321-330.
2. Stanietsky, N. and Mandelboim, O., Paired NK cell receptors controlling NK cytotoxicity. FEBS Lett. 2010. 584: 4895-4900.
3. Yamada, E.and McVicar, D. W., Paired receptor systems of the innate immune system. Curr. Protoc. Immunol. 2008. 81: A.1X.1-A.1X.25.
4. Lanier, L. L.and Phillips, J. H., NK cell recognition of major histocompatibility complex class I molecules. Semin. Immunol. 1995. 7: 75-82.
5. Gewurz, B. E., Wang, E. W., Tortorella, D., Schust, D. J. and Ploegh, H. L., Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner. J. Virol. 2001. 75: 5197-5204.
6. Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V.et al., Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000. 287: 1031-1033.
7. Ljunggren, H. G. and Karre, K., In search of the "missing self": MHC molecules and NK cell recognition. Immunol. Today 1990. 11: 237-244.
8. Lopez-Botet, M., Angulo, A. and Guma, M., Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. Tissue Antigens 2004. 63: 195-203.
9. Beck, S. and Barrell, B. G., Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 1988. 331: 269-272.
10. Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson, L. and Hsu, M. L., A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997. 7: 273-282.
11. Kaiser, B. K., Pizarro, J. C., Kerns, J. and Strong, R. K., Structural basis for NKG2A/CD94 recognition of HLA-E. Proc. Natl. Acad. Sci. USA 2008. 105: 6696-6701.
12. Chapman, T. L., Heikema, A. P., West, A. P., Jr. and Bjorkman, P. J., Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity 2000. 13: 727-736.
13. Leong, C. C., Chapman, T. L., Bjorkman, P. J., Formankova, D., Mocarski, E. S., Phillips, J. H. and Lanier, L. L., Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J. Exp. Med. 1998. 187: 1681-1687.
14. Campbell, J. A., Trossman, D. S., Yokoyama, W. M. and Carayannopoulos, L. N., Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D. J. Exp. Med. 2007. 204: 1311-1317.
15. Fang, M., Lanier, L. L.and Sigal, L. J., A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog. 2008. 4: e30.
16. Campbell, J. A., Davis, R. S., Lilly, L. M., Fremont, D. H., French, A. R. and Carayannopoulos, L. N., Cutting edge: FcR-like 5 on innate B cells is targeted by a poxvirus MHC class I-like immunoevasin. J. Immunol. 2010. 185: 28-32.
17. Orr, M. T., Wu, J., Fang, M., Sigal, L. J., Spee, P., Egebjerg, T., Dissen, E. et al., Development and function of CD94-deficient natural killer cells. PLoS One 2010. 5: e15184.
18. Fang, M., Orr, M. T., Spee, P., Egebjerg, T., Lanier, L. L. and Sigal, L. J., CD94 is essential for NK cell-mediated resistance to a lethal viral disease. Immunity 2011. 34: 579-589.
19. Chalmer, J. E., Mackenzie, J. S.and Stanley, N. F., Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J. Gen. Virol. 1977. 37: 107-114.
20. Grundy, J. E., Mackenzie, J. S. and Stanley, N. F., Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect. Immun. 1981. 32: 277-286.
21. Bukowski, J. F., Warner, J. F., Dennert, G. and Welsh, R. M., Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J. Exp. Med. 1985. 161: 40-52.
22. Daniels, K. A., Devora, G., Lai, W. C., O'Donnell, C. L., Bennett, M. and Welsh, R. M., Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 2001. 194: 29-44.
23. Brown, M. G., Dokun, A. O., Heusel, J. W., Smith, H. R., Beckman, D. L., Blattenberger, E. A., Dubbelde, C. E. et al., Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001. 292: 934-937.
24. Gosselin, P., Mason, L. H., Willette-Brown, J., Ortaldo, J. R., McVicar, D. W. and Anderson, S. K., Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H. J. Leukoc. Biol. 1999. 66: 165-171.
25. Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B.and Lanier, L. L., Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002. 296: 1323-1326.
26. Smith, H. R., Heusel, J. W., Mehta, I. K., Kim, S., Dorner, B. G., Naidenko, O. V., Iizuka, K. et al., Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 2002. 99: 8826-8831.
27. Adams, E. J., Juo, Z. S., Venook, R. T., Boulanger, M. J., Arase, H., Lanier, L. L. and Garcia, K. C., Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors. Proc. Natl. Acad. Sci. USA 2007. 104: 10128-10133.
28. Lanier, L. L., Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 2008. 8: 259-268.
29. Kavanagh, D. G., Gold, M. C., Wagner, M., Koszinowski, U. H. and Hill, A. B., The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J. Exp. Med. 2001. 194: 967-978.
30. Kielczewska, A., Pyzik, M., Sun, T., Krmpotic, A., Lodoen, M. B., Munks, M. W., Babic, M.et al., Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J. Exp. Med. 2009. 206: 515-523.
31. Desrosiers, M. P., Kielczewska, A., Loredo-Osti, J. C., Adam, S. G., Makrigiannis, A. P., Lemieux, S., Pham, T. et al., Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat. Genet. 2005. 37: 593-599.
32. Carlyle, J. R., Jamieson, A. M., Gasser, S., Clingan, C. S., Arase, H. and Raulet, D. H., Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc. Natl. Acad. Sci. USA 2004. 101: 3527-3532.
33. Iizuka, K., Naidenko, O. V., Plougastel, B. F., Fremont, D. H. and Yokoyama, W. M., Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat. Immunol. 2003. 4: 801-807.
34. Plougastel, B., Dubbelde, C. and Yokoyama, W. M., Cloning of Clr, a new family of lectin-like genes localized between mouse Nkrp1a and Cd69. Immunogenetics 2001. 53: 209-214.
35. Voigt, S., Mesci, A., Ettinger, J., Fine, J. H., Chen, P., Chou, W. and Carlyle, J. R., Cytomegalovirus evasion of innate immunity by subversion of the NKR-P1B:Clr-b missing-self axis. Immunity 2007. 26: 617-627.
36. Hao, L., Klein, J. and Nei, M., Heterogeneous but conserved natural killer receptor gene complexes in four major orders of mammals. Proc. Natl. Acad. Sci. USA 2006. 103: 3192-3197.
37. Akkaya, M. and Barclay, A. N., Heterogeneity in the CD200R paired receptor family. Immunogenetics 2010. 62: 15-22.
38. Wright, G. J., Cherwinski, H., Foster-Cuevas, M., Brooke, G., Puklavec, M. J., Bigler, M., Song, Y. et al., Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J. Immunol. 2003. 171: 3034-3046.
39. Foster-Cuevas, M., Wright, G. J., Puklavec, M. J., Brown, M. H. and Barclay, A. N., Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor. J. Virol. 2004. 78: 7667-7676.
40. Langlais, C. L., Jones, J. M., Estep, R. D. and Wong, S. W., Rhesus rhadinovirus R15 encodes a functional homologue of human CD200. J. Virol. 2006. 80: 3098-3103.
41. Shiratori, I., Yamaguchi, M., Suzukawa, M., Yamamoto, K., Lanier, L. L., Saito, T. and Arase, H., Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200. J. Immunol. 2005. 175: 4441-4449.
42. Foster-Cuevas, M., Westerholt, T., Ahmed, M., Brown, M. H., Barclay, A. N. and Voigt, S., Cytomegalovirus e127 protein interacts with the inhibitory CD200 receptor. J. Virol. 2011. 85: 6055-6059.
43. McGeoch, D. J., Cook, S., Dolan, A., Jamieson, F. E. and Telford, E. A., Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J. Mol. Biol. 1995. 247: 443-458.
44. Cameron, C. M., Barrett, J. W., Liu, L., Lucas, A. R. and McFadden, G., Myxoma virus M141R expresses a viral CD200 (vOX-2) that is responsible for down-regulation of macrophage and T-cell activation in vivo. J. Virol. 2005. 79: 6052-6067.
45. Zhang, L., Stanford, M., Liu, J., Barrett, C., Jiang, L., Barclay, A. N. andMcFadden, G., Inhibition of macrophage activation by the myxoma virus M141 protein (vCD200). J. Virol. 2009. 83: 9602-9607.
46. Kanazawa, N., Okazaki, T., Nishimura, H., Tashiro, K., Inaba, K.and Miyachi, Y., DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif. J. Invest. Dermatol. 2002. 118: 261-266.
47. Kanazawa, N., Tashiro, K., Inaba, K. and Miyachi, Y., Dendritic cell immunoactivating receptor, a novel C-type lectin immunoreceptor, acts as an activating receptor through association with Fc receptor gamma chain. J. Biol. Chem. 2003. 278: 32645-32652.
48. Lambert, A. A., Gilbert, C., Richard, M., Beaulieu, A. D. and Tremblay, M. J., The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways. Blood 2008. 112: 1299-1307.
49. Lambert, A. A., Barabe, F., Gilbert, C. and Tremblay, M. J., DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway. Blood 2011. 117: 6589-6599.
50. + T cells. PLoS Pathog. 2010. 6: e1001188.
51. Jiang, L. and Barclay, A. N., Identification of leucocyte surface protein interactions by high-throughput screening with multivalent reagents. Immunology 2010. 129: 55-61.
52. Watt, S. M., Fawcett, J., Murdoch, S. J., Teixeira, A. M., Gschmeissner, S. E., Hajibagheri, N. M. and Simmons, D. L., CD66 identifies the biliary glycoprotein (BGP) adhesion molecule: cloning, expression, and adhesion functions of the BGPc splice variant. Blood 1994. 84: 200-210.
53. Watt, S. M., Teixeira, A. M., Zhou, G. Q., Doyonnas, R., Zhang, Y., Grunert, F., Blumberg, R. S.et al., Homophilic adhesion of human CEACAM1 involves N-terminal domain interactions: structural analysis of the binding site. Blood 2001. 98: 1469-1479.
54. Hill, D. J., Toleman, M. A., Evans, D. J., Villullas, S., Van Alphen, L. and Virji, M., The variable P5 proteins of typeable and non-typeable Haemophilus influenzae target human CEACAM1. Mol. Microbiol. 2001. 39: 850-862.
55. Hill, D. J. and Virji, M., A novel cell-binding mechanism of Moraxella catarrhalis ubiquitous surface protein UspA: specific targeting of the N-domain of carcinoembryonic antigen-related cell adhesion molecules by UspA1. Mol. Microbiol. 2003. 48: 117-129.
56. Virji, M., Watt, S. M., Barker, S., Makepeace, K. and Doyonnas, R., The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae. Mol. Microbiol. 1996. 22: 929-939.
57. + T lymphocytes. Nat. Immunol. 2002. 3: 229-236.
58. Slevogt, H., Zabel, S., Opitz, B., Hocke, A., Eitel, J., N'Guessan P. D., Lucka, L. et al., CEACAM1 inhibits Toll-like receptor 2-triggered antibacterial responses of human pulmonary epithelial cells. Nat. Immunol. 2008. 9: 1270-1278.
59. Schmitter, T., Agerer, F., Peterson, L., Munzner, P. and Hauck, C. R., Granulocyte CEACAM3 is a phagocytic receptor of the innate immune system that mediates recognition and elimination of human-specific pathogens. J. Exp. Med. 2004. 199: 35-46.
60. Leusch, H. G., Drzeniek, Z., Markos-Pusztai, Z. and Wagener, C., Binding of Escherichia coli and Salmonella strains to members of the carcinoembryonic antigen family: differential binding inhibition by aromatic alpha-glycosides of mannose. Infect. Immun. 1991. 59: 2051-2057.
61. Leusch, H. G., Hefta, S. A., Drzeniek, Z., Hummel, K., Markos-Pusztai, Z.and Wagener, C., Escherichia coli of human origin binds to carcinoembryonic antigen (CEA) and non-specific crossreacting antigen (NCA). FEBS Lett. 1990. 261: 405-409.
62. Dveksler, G. S., Dieffenbach, C. W., Cardellichio, C. B., McCuaig, K., Pensiero, M. N., Jiang, G. S., Beauchemin, N. et al., Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J. Virol. 1993. 67: 1-8.
63. Dveksler, G. S., Pensiero, M. N., Cardellichio, C. B., Williams, R. K., Jiang, G. S., Holmes, K. V. and Dieffenbach, C. W., Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 1991. 65: 6881-6891.
64. Kammerer, R. and Zimmermann, W., Coevolution of activating and inhibitory receptors within mammalian carcinoembryonic antigen families. BMC Biol. 2010. 8: 12.
65. Takai, T., Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology 2005. 115: 433-440.
66. Kubagawa, H., Burrows, P. D.and Cooper, M. D., A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc. Natl. Acad. Sci. USA 1997. 94: 5261-5266.
67. Nakayama, M., Underhill, D. M., Petersen, T. W., Li, B., Kitamura, T., Takai, T. and Aderem, A., Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. J. Immunol. 2007. 178: 4250-4259.
68. Atwal, J. K., Pinkston-Gosse, J., Syken, J., Stawicki, S., Wu, Y., Shatz, C. and Tessier-Lavigne, M., PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 2008. 322: 967-970.
69. Crocker, P. R., Paulson, J. C. and Varki, A., Siglecs and their roles in the immune system. Nat. Rev. Immunol. 2007. 7: 255-266.
70. Cao, H.and Crocker, P. R., Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation? Immunology 2011. 132: 18-26.
71. Razi, N. and Varki, A., Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation. Glycobiology 1999. 9: 1225-1234.
72. Carlin, A. F., Uchiyama, S., Chang, Y. C., Lewis, A. L., Nizet, V. and Varki, A., Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood 2009. 113: 3333-3336.
73. Vimr, E. and Lichtensteiger, C., To sialylate, or not to sialylate: that is the question. Trends Microbiol. 2002. 10: 254-257.
74. Carlin, A. F., Lewis, A. L., Varki, A. and Nizet, V., Group B streptococcal capsular sialic acids interact with Siglecs (immunoglobulin-like lectins) on human leukocytes. J. Bacteriol. 2007. 189: 1231-1237.
75. Delputte, P. L. and Nauwynck, H. J., Porcine arterivirus infection of alveolar macrophages is mediated by sialic acid on the virus. J. Virol. 2004. 78: 8094-8101.
76. Khatua, B., Ghoshal, A., Bhattacharya, K., Mandal, C., Saha, B. and Crocker, P. R., Sialic acids acquired by Pseudomonas aeruginosa are involved in reduced complement deposition and siglec mediated host-cell recognition. FEBS Lett. 584: 555-561.
77. Erdmann, H., Steeg, C., Koch-Nolte, F., Fleischer, B.and Jacobs, T., Sialylated ligands on pathogenic Trypanosoma cruzi interact with Siglec-E (sialic acid-binding Ig-like lectin-E). Cell Microbiol. 2009. 11: 1600-1611.
78. Jones, C., Virji, M. andCrocker, P. R., Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol. Microbiol. 2003. 49: 1213-1225.
79. Monteiro, V. G., Lobato, C. S., Silva, A. R., Medina, D. V., de Oliveira, M. A., Seabra, S. H., de Souza, W. et al., Increased association of Trypanosoma cruzi with sialoadhesin positive mice macrophages. Parasitol. Res. 2005. 97: 380-385.
80. Carlin, A. F., Chang, Y. C., Areschoug, T., Lindahl, G., Hurtado-Ziola, N., King, C. C., Varki, A. et al., Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. J. Exp. Med. 2009. 206: 1691-1699.
81. Nordstrom, T., Movert, E., Olin, A. I., Ali, S. R., Nizet, V., Varki, A.and Areschoug, T., Human Siglec-5 inhibitory receptor and immunoglobulin A (IgA) have separate binding sites in streptococcal beta protein. J. Biol. Chem. 2011. 286: 33981-33991.
82. Sun, Y., Senger, K., Baginski, T. K., Mazloom, A., Chinn, Y., Pantua, H., Hamidzadeh, K.et al., Evolutionarily conserved paired immunoglobulin-like receptor alpha (PILRalpha) domain mediates its interaction with diverse sialylated ligands. J. Biol. Chem. 2012. 287: 15837-15850.
83. Satoh, T., Arii, J., Suenaga, T., Wang, J., Kogure, A., Uehori, J., Arase, N. et al., PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell 2008. 132: 935-944.
84. Wang, J., Fan, Q., Satoh, T., Arii, J., Lanier, L. L., Spear, P. G., Kawaguchi, Y. et al., Binding of herpes simplex virus glycoprotein B (gB) to paired immunoglobulin-like type 2 receptor alpha depends on specific sialylated O-linked glycans on gB. J. Virol. 2009. 83: 13042-13045.
85. Arase, H.and Lanier, L. L., Virus-driven evolution of natural killer cell receptors. Microbes Infect. 2002. 4: 1505-1512.
86. Arase, H.and Lanier, L. L., Specific recognition of virus-infected cells by paired NK receptors. Rev. Med. Virol. 2004. 14: 83-93.
87. Cheng, T. P., French, A. R., Plougastel, B. F., Pingel, J. T., Orihuela, M. M., Buller, M. L. and Yokoyama, W. M., Ly49h is necessary for genetic resistance to murine cytomegalovirus. Immunogenetics 2008. 60: 565-573.
88. French, A. R., Pingel, J. T., Wagner, M., Bubic, I., Yang, L., Kim, S., Koszinowski, U. et al., Escape of mutant double-stranded DNA virus from innate immune control. Immunity 2004. 20: 747-756.
89. Voigt, V., Forbes, C. A., Tonkin, J. N., Degli-Esposti, M. A., Smith, H. R., Yokoyama, W. M.and Scalzo, A. A., Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc. Natl. Acad. Sci. USA 2003. 100: 13483-13488.
90. Angata, T., Hayakawa, T., Yamanaka, M., Varki, A. and Nakamura, M., Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates. FASEB J. 2006. 20: 1964-1973.
91. Liao, D., Concerted evolution: molecular mechanism and biological implications. Am. J. Hum. Genet. 1999. 64: 24-30.
92. Barrow, A. D. and Trowsdale, J., The extended human leukocyte receptor complex: diverse ways of modulating immune responses. Immunol. Rev. 2008. 224: 98-123.
93. Gorczynski, R. M., Chen, Z., Lee, L., Yu, K. and Hu, J., Anti-CD200R ameliorates collagen-induced arthritis in mice. Clin. Immunol. 2002. 104: 256-264.
94. Van Valen, L., Two modes of evolution. Nature 1974. 252: 298-300.
95. Varki, A. and Angata, T., Siglecs-the major subfamily of I-type lectins. Glycobiology 2006. 16: 1R-27R.
96. Barclay, A. N. and Hatherley, D., The counterbalance theory for evolution and function of paired receptors. Immunity 2008. 29: 675-678.
97. Nei, M., Gu, X. and Sitnikova, T., Evolution by the birth-and-death process in multigene families of the vertebrate immune system. Proc. Natl. Acad. Sci. USA 1997. 94: 7799-7806.
98. Abi-Rached, L. and Parham, P., Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J. Exp. Med. 2005. 201: 1319-1332.
99. Hooper, L. V., Littman, D. R. and Macpherson, A. J., Interactions between the microbiota and the immune system. Science 2012. 336: 1268-1273.
100. Mihrshahi, R., Barclay, A. N. and Brown, M. H., Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells. J. Immunol. 2009. 183: 4879-4886.
101. Kaiser, B. K., Barahmand-Pour, F., Paulsene, W., Medley, S., Geraghty, D. E. and Strong, R. K., Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics. J. Immunol. 2005. 174: 2878-2884.